The inter-regional epidemiological study of childhood cancer (IRESCC): A case control study of aetiological factors in leukaemia and lymphoma

P. A. McKinney, R. A. Cartwright, J. M.T. Saiu, J. R. Mann, Charles Stiller, G. J. Draper, A. L. Hartley, P. A. Hopton, J. M. Birch, J. A. Waterhouse

Research output: Contribution to journalArticlepeer-review

119 Citations (Scopus)

Abstract

The inter-regional epidemiological study of childhood cancer analysed data on 234 children diagnosed with leukaemia or lymphoma and 468 controls matched for age and sex. A wide range of potential risk factors was examined, including prenatal exposure to x rays, maternal drug ingestion and smoking, child's medical history, and parental medical conditions and occupation. Calculations were completed for leukaemia or lymphoma and diagnostic subgroups, as defined by laboratory confirmed cell type. In utero exposure to narcotic analgesics was weakly associated with leukaemia or lymphoma but no other antenatal factors gave significant risks. New associations were identified for skin diseases in both parents and congential abnormalities in the mothers of children with leukaemia. For past medical conditions in the child, viral disease occurring under 6 months of age increased the risk for acute lymphoblastic leukaemia. Fewer children in the leukaemia or lymphoma group had been immunised compared with control groups. Case children diagnosed over the age of 9 years were more likely than controls to have had four or more previous episodes of illness. Overall, these results indicate that prenatal factors may be less important than postnatal or genetic influences in the development of leukaemia or lymphoma in children.

Original languageEnglish
Pages (from-to)279-287
Number of pages9
JournalArchives of Disease in Childhood
Volume62
Issue number3
DOIs
Publication statusPublished - 1987

Fingerprint

Dive into the research topics of 'The inter-regional epidemiological study of childhood cancer (IRESCC): A case control study of aetiological factors in leukaemia and lymphoma'. Together they form a unique fingerprint.

Cite this